Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results

This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer (PCa). A retrospective chart review identified 28 men with T deficiency who underwent T therapy (T group) for at least 6 months while on A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kacker, Ravi, Hult, Mariam, San Francisco, Ignacio F, Conners, William P, Rojas, Pablo A, Dewolf, William C, Morgentaler, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Invited Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736350/
https://www.ncbi.nlm.nih.gov/pubmed/26306850
http://dx.doi.org/10.4103/1008-682X.160270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736350/
https://www.ncbi.nlm.nih.gov/pubmed/26306850
http://dx.doi.org/10.4103/1008-682X.160270

Ejemplares similares